Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Citi
US Department of Justice
Fuji
Queensland Health
Cantor Fitzgerald
Healthtrust
AstraZeneca
Accenture
Boehringer Ingelheim

Generated: November 21, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 009866

« Back to Dashboard

NDA 009866 describes SOLU-CORTEF, which is a drug marketed by Pharmacia And Upjohn and is included in one NDA. It is available from three suppliers. Additional details are available on the SOLU-CORTEF profile page.

The generic ingredient in SOLU-CORTEF is hydrocortisone sodium succinate. There are sixty-five drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the hydrocortisone sodium succinate profile page.
Summary for 009866
Tradename:SOLU-CORTEF
Applicant:Pharmacia And Upjohn
Ingredient:hydrocortisone sodium succinate
Patents:0
Formulation / Manufacturing:see details
Pharmacology for NDA: 009866
Suppliers and Packaging for NDA: 009866
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
SOLU-CORTEF hydrocortisone sodium succinate INJECTABLE;INJECTION 009866 NDA Pharmacia and Upjohn Company LLC 0009-0005 0009-0005-01 1 VIAL, SINGLE-DOSE in 1 CARTON (0009-0005-01) > 8 mL in 1 VIAL, SINGLE-DOSE
SOLU-CORTEF hydrocortisone sodium succinate INJECTABLE;INJECTION 009866 NDA Pharmacia and Upjohn Company LLC 0009-0011 0009-0011-04 25 VIAL, SINGLE-DOSE in 1 CARTON (0009-0011-04) > 2 mL in 1 VIAL, SINGLE-DOSE (0009-0011-03)

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrengthEQ 100MG BASE/VIAL
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:Yes

Profile for product number 002

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrengthEQ 250MG BASE/VIAL
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:Yes

Profile for product number 003

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrengthEQ 500MG BASE/VIAL
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:Yes

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fish and Richardson
Chinese Patent Office
Covington
Cantor Fitzgerald
Chubb
Johnson and Johnson
Queensland Health
US Department of Justice
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.